Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
A. Sokal, P. Chappert, A. Roeser, G. Barba-Spaeth, S. Fourati, I. Azzaoui, A. Vandenberghe, I. Fernandez, M. Bouvier-Alias, E. Crickx, A. Beldi Ferchiou, S. Hue, L. Languille, S. Baloul, F. Noizat-Pirenne, M. Luka, J. Megret, M. Menager, J.-M. Pawlotsky, S. Fillatreau, F. A. Rey, J.-C. Weill, C.-A. Reynaud, M. Mahevas
Abstract
Memory B cells play a fundamental role in host defenses against viruses, but to date, their role have been relatively unsettled in the context of SARS-CoV-2. We report here a longitudinal single-cell and repertoire profiling of the B cell response up to 6 months in mild and severe COVID-19 patients. Distinct SARS-CoV-2 Spike-specific activated B cell clones fueled an early antibody-secreting cell burst as well as a durable synchronous germinal center response. While highly mutated memory B cells, including preexisting cross-reactive seasonal Betacoronavirus-specific clones, were recruited early in the response, neutralizing SARS-CoV-2 RBD-specific clones accumulated with time and largely contributed to the late remarkably stable memory B-cell pool. Highlighting germinal center maturation, these cells displayed clear accumulation of somatic mutations in their variable region genes over time. Overall, these findings demonstrate that an antigen-driven activation persisted and matured up to 6 months after SARS-CoV-2 infection and may provide long-term protection.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolution of Antibody Immunity to SARS-CoV-2
C. Gaebler, Z. Wang, … R. Patel·bioRxiv·Nov 3, 2020
- SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease
R. Reyes, K. Clarke, … E. M. Bunnik·bioRxiv·Sep 24, 2021
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Jan 25, 2021
- Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
R. Marzi, J. Bassi, … L. Piccoli·bioRxiv·Sep 30, 2022
- Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection
J. T. Sandberg, R. Varnaite, … S. Gredmark-Russ·bioRxiv·Mar 17, 2021
- Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
N. Sherina, A. Piralla, … Q. Pan-Hammarstrom·bioRxiv·Nov 6, 2020